AlgiPharma has been awarded a new four year grant from the Norwegian Research Council for the project “Treatment of Chronic Infective Disease with Alginate Oligomer Based Formulations”. This study will focus on extended long term safety studies and formulation changes to further develop the AlgiPharma drug candidate OligoG for the treatment of cystic fibrosis.
For further information, please contact:
Arne Dessen, Chairman of Board; email@example.com
Philip D. Rye R&D Director; firstname.lastname@example.org